In a research report issued Tuesday, Needham analyst Alan Carr reiterated a Hold rating on Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), after the drug maker reported third-quarter results and …
The biotech-verse is rumbling as Cempra Inc (NASDAQ:CEMP) shares tumble despite a positive AdCom vote and Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) surges ahead on …
Needham analyst Alan Carr weighs in on ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) after hosting a call last week with key opinion leader (KOL) Dr.
With Alibaba Group Holding Ltd (NYSE:BABA) preparing to release earnings, Needham analyst Kerry Rice reiterated a Buy rating on the stock, while raising the …
Analysts offer insights into a volatile biotech-verse amid Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) shares dipping on news of a program termination and Aurinia Pharmaceuticals (NASDAQ:AUPH) soaring on …
EndoChoice Holdings Inc EndoChoice Holdings Inc (NYSE:GI) shares jumped nearly 90% today following the news that Boston Scientific Corporation (NYSE:BSX) will acquire GI for $8.00 …
Enphase Energy Inc (NASDAQ:ENPH) shares dropped nearly 30% this morning, after the microinverter maker announced restructuring and cost savings initiative that will see the firm …
In a research report issued Friday, Needham analyst Alan Carr reiterated a Buy rating on shares of Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) with a price …
Cepheid (NASDAQ:CPHD) just announced it will be acquired by Danaher (DHR) for $53 per share at a sum of $4 billion in cash. …
In a research report released Wednesday, Needham analyst Edwin Mok reiterated a Hold rating on shares of Enphase Energy Inc (NASDAQ:ENPH), following the news …
